Variation In Genes Required For Normal Mitosis And Risk Of Breast Cancer

由 Olson, JE, Wang, X, Goode, EL, Pankratz, VS, Fredericksen, ZS, Vierkant, RA, Pharoah, P, Cerhan, JR, Couch, FJ
出版 2009

Biobanks and personalized medicine

由 Olson, J.E., Bielinski, S.J., Ryu, E., Winkler, E.M., Takahashi, P.Y., Pathak, J., Cerhan, J.R.
發表在 Clin Genet (2014)

Residential Proximity to Industrial Facilities and Risk of Non-Hodgkin Lymphoma

由 De Roos, AJ, Davis, S, Colt, JS, Blair, A, Airola, M, Severson, RK, Cozen, W, Cerhan, JR, Hartge, P, Nuckols, JR, Ward, MH
出版 2010

The Functional Assessment of Cancer Therapy – General (FACT-G) is valid for monitoring quality of life in non-Hodgkin lymphoma patients

由 Yost, KJ, Thompson, CA, Eton, DT, Allmer, C, Ehlers, SL, Habermann, TM, Shanafelt, TD, Maurer, MJ, Slager, SL, Link, BK, Cerhan, JR
出版 2012

Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma

由 Abdou, AM, Gao, X, Cozen, W, Cerhan, JR, Rothman, N, Martin, MP, Davis, S, Schenk, M, Chanock, SJ, Hartge, P, Carrington, M, Wang, SS
發表在 Leukemia (2010)

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

由 Katzmann, JA, Clark, R, Kyle, RA, Larson, DR, Therneau, TM, Melton, LJ, Benson, JT, Colby, CL, Dispenzieri, A, Landgren, O, Kumar, S, Bradwell, AR, Cerhan, JR, Rajkumar, SV
出版 2012

Event-Free Survival at 24 Months Captures Central Nervous System Relapse of Systemic Diffuse Large B-cell Lymphoma in the Immunochemotherapy Era

由 Thanarajasingam, G, Maurer, MJ, Farooq, U, Johnston, PB, Thompson, CA, Bennani, NN, Ansell, SM, Porrata, LF, Macon, WR, Syrbu, SI, Cerhan, JR, Habermann, TM, Link, BK, Witzig, TE, Nowakowski, GS
發表在 Br J Haematol (2017)

Widespread Use of Complementary and Alternative Medicine (CAM) among Non-Hodgkin Lymphoma (NHL) Survivors

由 Osian, S. Rausch, Leal, A.D., Allmer, C., Maurer, M.J., Nowakowski, G., Inwards, D.J., Macon, W.R., Ehlers, S.L., Weiner, G.J., Habermann, T.M., Cerhan, J.R., Thompson, C.A.
發表在 Leuk Lymphoma (2014)

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma

由 Hu, G, Dasari, S, Asmann, YW, Greipp, PT, Knudson, RA, Benson, HK, Li, Y, Eckloff, BW, Jen, Jin, Link, BK, Jiang, L, Sidhu, JS, Wellik, LE, Witzig, TE, Bennani, NN, Cerhan, JR, Boddicker, RL, Feldman, AL
發表在 Leukemia (2017)

Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation

由 Chakkera, H.A., Hanson, R.L., Raza, S.M., DiStefano, J.K., Millis, M.P., Heilman, R.L., Mulligan, D.C., Reddy, K.S., Mazur, M.J., Hamawi, K., Moss, A.A., Mekeel, K.L., Cerhan, J.R.
出版 2009

A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus

由 Cozen, W, Timofeeva, MN, Li, D, Diepstra, A, Hazelett, D, Delahaye-Sourdeix, M, Edlund, CK, Franke, L, Rostgaard, K, Van Den Berg, DJ, Cortessis, VK, Smedby, KE, Glaser, SL, H-J, Westra, Robison, LL, Mack, TM, Ghesquieres, H, Hwang, AE, Nieters, A, de Sanjose, S, Lightfoot, T, Becker, N, Maynadie, M, Foretova, L, Roman, E, Benavente, Y, Rand, KA, Nathwani, BN, Glimelius, B, Staines, A, Boffetta, P, Link, BK, Kiemeney, L, Ansell, SM, Bhatia, S, Strong, LC, Galan, P, Vatten, L, Habermann, TM, Duell, EJ, Lake, A, Veenstra, RN, Visser, L, Liu, Y, Urayama, KY, Montgomery, D, Gaborieau, V, Weiss, LM, Byrnes, G, Lathrop, M, Cocco, P, Best, T, Skol, AD, H-O, Adami, Melbye, M, Cerhan, JR, Gallagher, A, Taylor, GM, Slager, SL, Brennan, P, Coetzee, GA, Conti, DV, Onel, K, Jarrett, RF, Hjalgrim, H, van den Berg, A, McKay, JD
出版 2014